tiprankstipranks
Agile Therapeutics (AGRX)
OTHER OTC:AGRX
US Market

Agile Therapeutics (AGRX) Income Statement

1,500 Followers

Agile Therapeutics Income Statement

Last quarter (Q1 2024), Agile Therapeutics's total revenue was $5.72M, an increase of 43.08% from the same quarter last year. In Q1, Agile Therapeutics's net income was $1.28M. See Agile Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 19.39M$ 19.59M$ 10.88M$ 4.10M$ 749.00K$ 0.00
Cost of Revenue
$ 6.16M$ 8.98M$ -6.84M$ -10.72M$ 282.00K$ 0.00
Gross Profit
$ 13.23M$ 10.62M$ 4.05M$ -6.62M$ 467.00K$ 0.00
Operating Expense
$ 31.82M$ 30.50M$ -56.60M$ -64.39M$ 49.52M$ 18.86M
Operating Income
$ -18.59M$ -19.88M$ -41.43M$ -71.00M$ -49.05M$ -18.86M
Net Non Operating Interest Income Expense
$ -1.22M$ -10.32M$ -3.05M$ -3.89M$ -2.80M$ 252.00K
Other Income Expense
$ -9.41M$ -6.76M$ -14.40M$ 3.83M--
Pretax Income
$ -8.71M$ -14.46M$ -30.09M$ -71.07M$ -51.85M$ -18.61M
Tax Provision
--$ -4.67M-$ 0.00$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -8.71M$ -14.46M$ -25.41M$ -71.07M$ -51.85M$ -18.61M
Basic EPS
$ -8.05$ -6.71$ -1.18$ -38.50$ -24.40$ -0.38
Diluted EPS
$ -8.05$ -6.71$ -1.18$ -38.50$ -24.40$ -0.38
Basic Average Shares
$ 10.26M$ 2.16M$ 21.61M$ 1.94M$ 2.12M$ 49.43M
Diluted Average Shares
$ 10.26M$ 2.16M$ 21.61M$ 1.94M$ 2.12M$ 49.43M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 37.98M$ 39.48M$ -63.44M$ -75.11M$ 49.80M$ 18.86M
Net Income From Continuing And Discontinued Operation
$ -8.71M$ -14.46M$ -25.41M$ -71.07M$ -51.85M$ -18.61M
Normalized Income
$ -2.37M$ -35.09M--$ -51.85M$ -18.61M
Interest Expense
----$ 3.11M$ 0.00
EBIT
$ -7.41M$ -4.07M$ -28.12M$ -69.54M$ -48.74M$ -18.61M
EBITDA
$ -7.03M$ -3.68M$ -26.58M$ -67.31M$ -48.47M$ -18.44M
Currency in USD

Agile Therapeutics Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis